Shares of Haleon PLC Sponsored ADR (NYSE:HLN – Get Free Report) gapped down before the market opened on Wednesday . The stock had previously closed at $11.08, but opened at $10.31. Haleon shares last traded at $10.2630, with a volume of 2,868,990 shares trading hands.
Wall Street Analysts Forecast Growth
A number of analysts recently issued reports on the company. Morgan Stanley reiterated an “overweight” rating on shares of Haleon in a research note on Monday, December 15th. HSBC upgraded Haleon from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, January 21st. Weiss Ratings restated a “hold (c)” rating on shares of Haleon in a research report on Thursday, January 22nd. Deutsche Bank Aktiengesellschaft cut shares of Haleon from a “hold” rating to a “sell” rating in a research note on Monday, January 12th. Finally, Jefferies Financial Group reiterated a “buy” rating on shares of Haleon in a research note on Tuesday, January 20th. One investment analyst has rated the stock with a Strong Buy rating, four have given a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $12.33.
View Our Latest Stock Analysis on Haleon
Haleon Trading Down 6.3%
Institutional Inflows and Outflows
A number of institutional investors have recently added to or reduced their stakes in HLN. Morgan Stanley boosted its holdings in shares of Haleon by 16.0% in the 4th quarter. Morgan Stanley now owns 21,495,383 shares of the company’s stock worth $217,318,000 after purchasing an additional 2,962,856 shares in the last quarter. Norges Bank bought a new stake in Haleon in the 4th quarter worth approximately $163,529,000. Bank of America Corp DE boosted its stake in Haleon by 116.7% in the second quarter. Bank of America Corp DE now owns 12,384,135 shares of the company’s stock worth $128,423,000 after buying an additional 6,669,923 shares in the last quarter. JPMorgan Chase & Co. grew its position in Haleon by 36.6% during the third quarter. JPMorgan Chase & Co. now owns 11,984,672 shares of the company’s stock valued at $107,503,000 after acquiring an additional 3,207,986 shares during the last quarter. Finally, Sculptor Capital LP raised its stake in shares of Haleon by 5.1% during the fourth quarter. Sculptor Capital LP now owns 10,454,868 shares of the company’s stock worth $105,699,000 after acquiring an additional 505,000 shares in the last quarter. Institutional investors own 6.67% of the company’s stock.
About Haleon
Haleon plc (NYSE:HLN) is a global consumer healthcare company formed through the separation of a large pharmaceutical group’s consumer health business in 2022. Headquartered in the United Kingdom, Haleon develops, manufactures and markets a broad portfolio of over‑the‑counter medicines, oral health products, vitamins, minerals and supplements, and other consumer health goods designed for daily self‑care and symptom relief.
The company’s product mix spans categories such as oral care (toothpastes and sensitivity treatments), pain relief and analgesics, respiratory remedies, digestive health products, topical treatments and nutritional supplements.
See Also
- Five stocks we like better than Haleon
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- This makes me furious
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for Haleon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Haleon and related companies with MarketBeat.com's FREE daily email newsletter.
